坎格雷洛是一種用于2015年6月靜脈應(yīng)用的抗血小板藥物的PYY12抑制劑。一些P2Y12抑制劑被臨床用作二磷酸腺苷介導(dǎo)的血小板活化和聚集的有效抑制劑。與氯吡格雷（Pravix）不同，它是一種前藥，是一種不需要代謝轉(zhuǎn)化的活性藥物。
(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
4,6-Dihydroxy-2-mercaptopyrimidine
1,1,1-Trifluoro-3-iodopropane
(2-Chloroethyl)(methyl)sulfane
(2S,3R,4R,5R)-5-(Acetoxymethyl)tetrahydrofuran-2,3,4-triyl triacetate
(Dichloro((((((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)methyl)phosphonic acid tetrasodium salt
4,6-DICHLORO-2-((3,3,3-TRIFLUOROPROPYL)THIO)PYRIMIDIN-5-AMINE
N-(2-(METHYLTHIO)ETHYL)-2-((3,3,3-TRIFLUOROPROPYL)THIO)-9H-PURIN-6-AMINE
